Voyager Therapeutics (VYGR) Current Assets (2016 - 2025)
Historic Current Assets for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to $219.6 million.
- Voyager Therapeutics' Current Assets fell 4119.99% to $219.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $219.6 million, marking a year-over-year decrease of 4119.99%. This contributed to the annual value of $276.8 million for FY2024, which is 1341.17% down from last year.
- As of Q3 2025, Voyager Therapeutics' Current Assets stood at $219.6 million, which was down 4119.99% from $227.9 million recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Current Assets registered a high of $409.1 million during Q1 2024, and its lowest value of $124.5 million during Q4 2022.
- Its 5-year average for Current Assets is $235.9 million, with a median of $227.9 million in 2025.
- Its Current Assets has fluctuated over the past 5 years, first crashed by 4165.68% in 2021, then surged by 15677.64% in 2023.
- Quarter analysis of 5 years shows Voyager Therapeutics' Current Assets stood at $136.7 million in 2021, then dropped by 8.92% to $124.5 million in 2022, then surged by 156.78% to $319.7 million in 2023, then decreased by 13.41% to $276.8 million in 2024, then fell by 20.67% to $219.6 million in 2025.
- Its Current Assets stands at $219.6 million for Q3 2025, versus $227.9 million for Q2 2025 and $245.2 million for Q1 2025.